February 6, 2024 · Form 4 insider transaction
Shameze Rampertab bought 330,300 shares of Asensus Surgical, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.; PRSU award with time-based vesting in three equal installments on each of February 4, 2025, 2026 and 2027, and performance-based vesting only if designated corporate goals are met.